Guardant Health Inc Insider Trading
Every director, officer and 10% holder of Guardant Health Inc has to report each trade in its stock within two business days of making it. This is those filings.
GH on carbonthat →Purchases and sales
Open-market trades only — the lines where someone chose to buy or sell at the going price.
| Insider | Action | Value |
|---|---|---|
| Musa TariqDirector2026-09-16116 shat $175.00 | Sale10b5-1 plan | $20.3K |
| Steve E. KrognesDirector2026-09-161.1K shat $174.46 | Sale | $192.4K |
| Steve E. KrognesDirector2026-09-163.3K shat $175.42 | Sale | $578.9K |
| Steve E. KrognesDirector2026-09-161.3K shat $176.34 | Sale | $229.2K |
| Steve E. KrognesDirector2026-09-16971 shat $177.48 | Sale | $172.3K |
| Alex M Azar IIDirector2026-09-16826 shat $175.00 | Sale10b5-1 plan | $144.6K |
| Darya ChudovaChief Technology Officer2026-09-157.7K shat $178.00 | Sale | $1.4M |
| Kumud KaliaChief Information Officer2026-09-114K shat $158.05 | Sale | $632.2K |
| AmirAli TalasazCo-Chief Executive Officer2026-08-219K shat $168.20 | Sale | $1.5M |
| AmirAli TalasazCo-Chief Executive Officer2026-08-2120.9K shat $169.16 | Sale | $3.5M |
| AmirAli TalasazCo-Chief Executive Officer2026-08-217.6K shat $170.29 | Sale | $1.3M |
| Musa TariqDirector2026-08-17116 shat $156.45 | Sale10b5-1 plan | $18.1K |
| Terilyn J. MonroeChief People Officer2026-08-123.7K shat $163.41 | Sale | $605.3K |
| Terilyn J. MonroeChief People Officer2026-08-129.9K shat $164.27 | Sale | $1.6M |
| Terilyn J. MonroeChief People Officer2026-08-1219K shat $165.16 | Sale | $3.1M |
| Terilyn J. MonroeChief People Officer2026-08-1213.2K shat $166.11 | Sale | $2.2M |
| Terilyn J. MonroeChief People Officer2026-08-12400 shat $167.92 | Sale | $67.2K |
| Chris FreemanChief Commercial Officer2026-08-103.5K shat $167.38 | Sale | $579.6K |
| Chris FreemanChief Commercial Officer2026-08-107.4K shat $168.79 | Sale | $1.2M |
| Chris FreemanChief Commercial Officer2026-08-1035.4K shat $169.63 | Sale | $6M |
| Chris FreemanChief Commercial Officer2026-08-1017.4K shat $170.24 | Sale | $3M |
| Medina Manuel HidalgoDirector2026-08-05950 shat $163.95 | Sale | $155.7K |
| Medina Manuel HidalgoDirector2026-08-05750 shat $164.61 | Sale | $123.5K |
| Ian T ClarkDirector2026-08-049.1K shat $158.98 | Sale | $1.4M |
| Ian T ClarkDirector2026-08-045.1K shat $158.80 | Sale | $808.6K |
| Musa TariqDirector2026-07-16116 shat $163.29 | Sale10b5-1 plan | $18.9K |
| AmirAli TalasazCo-Chief Executive Officer2026-06-2925.8K shat $150.53 | Sale10b5-1 plan | $3.9M |
| AmirAli TalasazCo-Chief Executive Officer2026-06-2970.5K shat $151.47 | Sale10b5-1 plan | $10.7M |
| AmirAli TalasazCo-Chief Executive Officer2026-06-2946.7K shat $152.20 | Sale10b5-1 plan | $7.1M |
| AmirAli TalasazCo-Chief Executive Officer2026-06-2940 shat $153.00 | Sale10b5-1 plan | $6.1K |
| AmirAli TalasazCo-Chief Executive Officer2026-06-2664K shat $150.49 | Sale10b5-1 plan | $9.6M |
| AmirAli TalasazCo-Chief Executive Officer2026-06-2652.9K shat $151.16 | Sale10b5-1 plan | $8M |
| Kumud KaliaChief Information Officer2026-06-15600 shat $130.76 | Purchase | $78.5K |
| Kumud KaliaChief Information Officer2026-06-15600 shat $131.08 | Sale | $78.6K |
| Kumud KaliaChief Information Officer2026-06-10600 shat $130.86 | Sale | $78.5K |
Source: SEC Form 4 filings, via EDGAR. A derivative line reports the shares underlying an option rather than stock outstanding, so it is marked and is not comparable with the rest. Value is shares times the reported price, and is blank where the filing priced the transaction at zero — a grant costs its recipient nothing. Insiders sell for reasons that have nothing to do with the company, which is why a sale is not read as a signal on its own.
More on GH
Follow Guardant Health Inc (GH) by email
New trades in Guardant Health Inc (GH) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.